| 영문 | oral administration | 한글 | 경구복용 |
|---|---|---|---|
| 설명 | 약을 투여하는 방법에는 여러 가지가 있다. 크게 나누어 보면, 입을 거쳐 위창자계를 통해 넣는 방법과 위창자계를 통하지 않고 바로 혈액으로 넣는 방법이 있다. 위창자계를 통하지 않는 방법으로 가장 흔한 방법은 주사를 이용하는 방법이다. 하지만, 이외에 항문을 통해 넣는 좌약식방법과 혀밑에 넣는 혀밑투여법도 있다. 그러나 대부분의 약제는 경구복용을 하게 된다. 경구복용에 대한 약자는 p.o.(per oral)로 표기한다. 경구복용제의 단점은 복용한 약제가 위창자관계를 거치면서 사람마다 각기 다른 흡수정도와 대사정도를 거치게 되므로 일정한 농도유지가 어렵다는데 있다. 또한 경구복용제의 모양이 캡슐형인지, 혹은 가루형인지에 따라서도 같은 약이지만, 서로 다른 효과를 나타낼 수 있다. |
||
| 영문 | oral cavity | 한글 | 구강 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다.  |
||
| 영문 | oral cavity | 한글 | 입안 |
|---|---|---|---|
| 설명 | 입을 벌여서 입속에서 볼 수 있는 공간으로 입천장, 편도, 목젖을 볼 수 있다. |
||
| ORS | olfactory reference syndrome; oral rehydration solution; oral surgery, oral surgeon; Orthopaedic Res... |
|---|---|
| DLI | distolinguoincisal; double label index |
| BC/BS | Blue Cross/Blue Shield [plan] |
| BCBSA | Blue Cross and Blue Shield Association |
| BCP | basic calcium phosphate; birth control pill; blue cone pigment; Blue Cross Plan; bromcresol purple |
| DMMB | 1,9-dimethyl methylene blue |
|---|---|
| AB | Alcian Blue |
| AB-PAS | Alcian blue-periodic acid Schiff |
| BN-PAGE | Blue Native polyacrylamide gel electrophoresis |
| BRBNS | Blue Rubber Bleb Nevus Syndrome |
| radio label | A mildly radioactive molecule that is used to tag another molecule (such as a protein) so that it can be identified as it goes through some kind of biochemical process. (09 Oct 1997) |
|---|---|
| chromogenic label | A molecule which can be used as a label to a biological probe molecule because it forms a coloured compound when the probe molecule is attached to its target. (09 Oct 1997) |
| off-label | Use of a drug for a disease or condition other than the indication for which it was approved by the FDA. For example: many doctors prescribe paromomycin (humatin) for cryptosporidiosis, although it is not approved for treating this disease. (09 Oct 1997) |
| off-label use | In the United States, the regulations of the Food and drug administration (FDA) permit physicians to prescribe approved medications for other than their intended indications. This practice is known as off-label use. (12 Dec 1998) |
| open-label trial | A study in which both researchers and participants know what drug a person is taking and at what dose. (09 Oct 1997) |
| label | 1. To incorporate into a compound a substance that is readily detected, such as a radionuclide, whereby its metabolism can be followed or its physical distribution detected. 2. The substance so incorporated. (05 Mar 2000) |
| fluorescent label | A molecule which fluoresces and can be attached to a probe molecule that does not fluoresce. (09 Oct 1997) |
| maximum | 1. The greatest possible or actual effect or quantity. 2. The acme of a disease or process. (18 Nov 1997) |
| maximum breathing capacity | The volume of air breathed when an individual breathes as deeply and as quickly as possible for a given time (e.g., 15 sec.). Synonym: maximum breathing capacity. (05 Mar 2000) |
| maximum occipital point | The point on the squama of the occipital bone farthest from the glabella. (05 Mar 2000) |
| maximum permissible dose | <radiobiology> Defined by the International Commission on Radiological Protection as the greatest dose of radiation which, in the light of present knowledge, is not expected to cause detectable bodily injury to a person at any time during his lifetime. This dose has been reduced with each Commission report. The MPD is given in terms of acute or chronic exposure of the whole body or of organs, systems, or regions of the body, and differs for persons who are occupationally exposed versus the public at large. (05 Mar 2000) |
| maximum permissible exposure level | The highest level of exposure to a substance, usually noxious, in the environment or during diagnostic and therapeutic procedures, that a body can tolerate without injury. (12 Dec 1998) |
| maximum temperature | In bacteriology, denoting a temperature above which growth will not take place. (05 Mar 2000) |
| maximum urea clearance | The urea clearance when the urine flow exceeds 2 ml/min; normal value is about 75 ml blood/min per 1.73 m2 body surface area. (05 Mar 2000) |
| maximum velocity | The maximum rate of an enzyme-catalyzed reaction that can be achieved by progressively increasing the substrate concentration at a given enzyme concentration; in cases of substrate inhibition, Vmax is an extrapolated value in the absence of such inhibition; Cf.: Michaelis-Menten equation. The maximum initial rate of shortening of a myocardial fibre that can be obtained under zero load; used to evaluate the contractility of the fibre. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|